发明名称 |
Controlled release formulations of octreotide |
摘要 |
A formulation of octreotide or pharmaceutically acceptable salts thereof, which provides controlled release of a therapeutically effective amount of octreotide for a period of at least about two months. Methods of treating acromegaly, decreasing growth hormone, decreasing IGF-1, and treating conditions associated with carcinoid tumors and VIPomas by administering a controlled release formulation of octreotide are provided herein.
|
申请公布号 |
EP2455072(A1) |
申请公布日期 |
2012.05.23 |
申请号 |
EP20120156089 |
申请日期 |
2006.03.10 |
申请人 |
ENDO PHARMACEUTICALS SOLUTIONS INC. |
发明人 |
KUZMA, PETR;DECKER, STEPHANIE |
分类号 |
A61K9/50;A61K9/52;A61K38/31 |
主分类号 |
A61K9/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|